Breaking NewsHealth

SHEIKH MOHAMMED BIN RASHID HAS RECEIVED COVID-19 VACCINE

Sheikh Muhammed receiving a jab
By Our Correspondent

Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, has received the Covid-19 vaccine, according to a post on his Twitter account today, Tuesday, November 3rd, 2020.

According to his twitter post, he thanked all those working to develop a vaccine for the coronavirus.

“While receiving the Covid-19 vaccine today. We wish everyone safety and great health, and we are proud of our teams who have worked relentlessly to make the vaccine available in the UAE,” he said.

“The future will always be better in the UAE,” Sheikh asserted.

The Prime Minister was the latest senior figure in the UAE to take China’s Sinopharm vaccine.

The country hosted a Phase-3 trial that involved 31,000 volunteers in the Emirates, Bahrain and Jordan.

The jab has since been administered to frontline medical workers, senior officials and some members of the Cabinet, after it received approval from the UAE Government for limited use in September.

At the weekend, Mohammed Al Gergawi, Minister of Cabinet Affairs and Sheikh Rashid bin Humaid Al Nuaimi, president of the UAE Football Association and a member of Ajman’s ruling family, also received the vaccine.

Sheikh Rashid said he looked forward to “victory over the virus”.

Among the other high profile leaders to receive the vaccine was Sheikh Abdullah bin Zayed, Minister of Foreign Affairs and International Cooperation and Sheikh Khalid bin Mohamed bin Zayed, chairman of Abu Dhabi Executive Office.

In other developments on Tuesday, Bahrain granted emergency approval for the use of a Sinopharm vaccine on frontline workers, state news agency BNA said.

China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration.
China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.